The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Open accessAbstract
INTRODUCTION: Polypharmacy, the use of multiple medications by one individual, is increasingly common among older adults. Caring for the growing number of older people with complex drug regimens and multimorbidity presents an important challenge in the coming years. AREAS COVERED: This article reviews the international trends in the prevalence of polypharmacy, summarizes the results from previous reviews on polypharmacy and negative health outcomes, and updates a previous review on the clinical consequences of polypharmacy by focusing on studies published after 2013. This narrative review, which is based on a literature search in MEDLINE and EMBASE from January 1990 to June 2018, was undertaken to identify relevant articles. Search terms included variations of polypharmacy and multiple medications. EXPERT OPINION: The prevalence of polypharmacy is increasing worldwide. More than half of the older population is exposed to polypharmacy in some settings. Polypharmacy is associated with a broad range of clinical consequences. However, methods to assess the dangers of polypharmacy should be refined. In our opinion, the issue of 'confounding by multimorbidity' has been underestimated and should be better accounted for in future studies. Moreover, researchers should develop more clinically relevant definitions of polypharmacy, including measures of inappropriate or problematic polypharmacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic BZD use is also a concern for older adults as they are likely to be prescribed multiple medications, increasing their risk of morbidity and mortality from polypharmacy.94,95”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [94]
In the citing paper
“Chronic BZD use is also a significant concern for older adults given they are likely to be prescribed multiple medications, increasing their risk of morbidity and mortality from polypharmacy.94,95”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [94]
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,397
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
Research works printed but not linked: 4
- O’Mahony D, 2015, Age Ageing, 44
- Duerden M, 2013, Polypharmacy and medicines optimisation: making it safe and sound
- Alhawassi TM, 2014, Clin Interv Aging, 9, 2079
- Calderón-Larrañaga A, 2016, J Gerontol Ser A Biomed Sci Med Sci, 72, 1417
Cited by
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
An overview of prevalence, determinants and health outcomes of polypharmacy
Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620933741 · Cited by 443
Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
Nicholson, K., Liu, W., Fitzpatrick, D., Hardacre, K. A., Roberts, S., Salerno, J., Stranges, S., Fortin, M., & Mangin, D. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00007-2 · Cited by 263
Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study
Chang, T. I., Park, H., Kim, D. W., Jeon, E. K., Rhee, C. M., Kalantar-Zadeh, K., Kang, E. W., Kang, S.-W., & Han, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-75888-8 · Cited by 263
Barriers and facilitators to deprescribing in primary care: a systematic review
Doherty, A. J., Boland, P., Reed, J., Clegg, A. J., Stephani, A.-M., Williams, N. H., Shaw, B., Hedgecoe, L., Hill, R., & Walker, L. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101096 · Cited by 247
Metadata
- Authors
- Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K.
- Affiliations
- Stockholm University (SE)
- Corresponding author
- Wastesson, Jonas W.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2018-12-02
- Volume
- 17
- Issue
- 12
- Pages
- 1185-1196
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2904281537
- Cited by
- 617
- References
- 96
- Citations by year
- 2026: 82 · 2025: 86 · 2024: 95 · 2023: 91 · 2022: 80 · 2021: 78 · 2020: 63 · 2019: 21
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Expert Opinion on Drug Safety (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet (2015-03618)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- polypharmacy, older adults, multimorbidity, inappropriate prescribing, polypharmacy prevalence, adverse drug reactions, drug safety
- MeSH terms
- Age Factors, Aged, Pharmaceutical Preparations, Humans, Prevalence, Polypharmacy, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update on the clinical consequences of polypharmacy in older adults: a narrative review. https://app.cochat.ai/papers/10.1080/14740338.2018.1546841
- The paper
- Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018). An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2018.1546841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.